11. P658 Comparative Efficacy and Safety of Upadacitinib Versus Tofacitinib as Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: A Matching-Adjusted Indirect Comparison. (30th January 2023) Authors: Reinisch, W; Tran, J; Patel, K; Borruel, N; Melmed, G Y; Wegrzyn, L; Levy, G; Ilo, D; Sanchez Gonzalez, Y; Panaccione, R Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗